In the field of precision medicine, in vitro diagnostic devices (IVDs), such as companion diagnostics (CDx) and clinical trial assays (CTA), are vital for biomarker-driven subject eligibility, ...
To commemorate the 10th anniversary of its one-of-a-kind corporate philanthropy model, Alorica Inc., a global leader in digitally powered customer experience solutions, announced today that MLBA has ...
Discover why Janux Therapeutics, Inc.'s promising immunotherapy data and strong cash position draw attention—plus key risks.
Non-registered accounts held individually can lead to frozen funds and probate fees. Learn how joint accounts can protect ...
LPL Financial LLC announced today that the partners of Edge Wealth Advisory Group have joined LPL Financial’s broker-dealer and Registered Investment Advisor (RIA) platform. They reported serving ...
(Head of Commercial: Mike Petroutsas, "Astellas") today announced final overall survival (OS) results from the Phase 3 EMBARK study evaluating XTANDI ® (enzalutamide), in combination with leuprolide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results